Latest Articles
Ovum Launches with $1.7M Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider
Ovum Launches with $1.7M Funding to Develop AI-Powered Women’s Health Platform Femtech Insider
Published: Aug. 7, 2025, 7:33 a.m.
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform Femtech Insider
Published: Aug. 7, 2025, 7:08 a.m.
YC’s Fall 2025 Startup Requests: What They Signal for Women’s Health Innovation - Femtech Insider
YC’s Fall 2025 Startup Requests: What They Signal for Women’s Health Innovation Femtech Insider
Published: Aug. 6, 2025, 8:31 a.m.
Insights into the Molecular Mechanisms and Signaling Pathways of Epithelial to Mesenchymal Transition (EMT) in the Pathophysiology of Endometriosis.
Endometriosis is a disease characterized by the presence of endometrial glands and stroma outside of the uterine corpus, often clinically presenting with pain and/or infertility. Ectopic lesions exhibit features characteristic …
Published: Aug. 1, 2025, midnight
Figure 3. Mechanisms of action of related EMT and MMPs in EMS, OC, BC,... - researchgate.net
Figure 3. Mechanisms of action of related EMT and MMPs in EMS, OC, BC,... researchgate.net
Published: July 31, 2025, 9:34 p.m.
What’s New in Femtech This Week? (July 31, 2025) - Femtech Insider
What’s New in Femtech This Week? (July 31, 2025) Femtech Insider
Published: July 31, 2025, 7:59 a.m.
Penn State Researchers Develop 10-Minute At-Home Endometriosis Test Using Menstrual Blood - Femtech Insider
Penn State Researchers Develop 10-Minute At-Home Endometriosis Test Using Menstrual Blood Femtech Insider
Published: July 28, 2025, 6:20 a.m.
What’s New in Femtech This Week? (July 24, 2025) - Femtech Insider
What’s New in Femtech This Week? (July 24, 2025) Femtech Insider
Published: July 25, 2025, 7:59 a.m.
Gesynta Pharma Adds $3.9M in Series B Funding for Endometriosis Drug, Total Round Reaches $31.5M - Femtech Insider
Gesynta Pharma Adds $3.9M in Series B Funding for Endometriosis Drug, Total Round Reaches $31.5M Femtech Insider
Published: July 23, 2025, 5:39 a.m.
Gesynta Pharma Raises Additional $3.9M in Series B Second Closing, Total Round Reaches $31.5M - Femtech Insider
Gesynta Pharma Raises Additional $3.9M in Series B Second Closing, Total Round Reaches $31.5M Femtech Insider
Published: July 23, 2025, 5:34 a.m.
Link copied to clipboard!